Researchers with the U.S. Department of Energy (DOE)'s Lawrence Berkeley
National Laboratory (Berkeley Lab) have found new evidence to explain
how cholesteryl ester transfer protein (CETP) mediates the transfer of
cholesterol from "good" high density lipoproteins (HDLs) to "bad" low
density lipoproteins (LDLs). These findings point the way to the design
of safer, more effective next generation CETP inhibitors that could help
prevent the development of heart disease.
No comments:
Post a Comment